Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Verga

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Henry Ford Hospital Medical Journal|January 1, 1989
The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinomaU Verga, F Muratori, G Di Sacco, et al.
Henry Ford Hospital Medical Journal|January 1, 1989
Use of somatostatin analog SMS 201-995 in medullary thyroid carcinomaA Libroia, U Verga, G Di Sacco, et al.
Henry Ford Hospital Medical Journal|January 1, 1992
Evaluation of children with medullary thyroid carcinomaA Libroia, F Muratori, U Verga, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Loss of heterozygosity at the RET protooncogene locus in a case of multiple endocrine neoplasia type 2AL Quadro, O Fattoruso, M P Cosma, et al.
Journal of Endocrinological Investigation|May 19, 1998
Seventeen-year-long follow-up of a family affected by type 2A multiple endocrine neoplasia (MEN 2A)A Libroia, U Verga, G Vecchi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 1997
A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinomaR M Hofstra, O Fattoruso, L Quadro, et al.
Clinical Endocrinology|September 27, 2005
Ghrelin in human medullary thyroid carcinomasP S Morpurgo, V Cappiello, U Verga, et al.
Molecular and Cellular Endocrinology|June 2, 1998
Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomasC Scurini, L Quadro, O Fattoruso, et al.
Journal of Endocrinological Investigation|March 15, 2005
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomasM Filopanti, E Ballarè, A G Lania, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Henry Ford Hospital Medical Journal|January 1, 1989
The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinomaU Verga, F Muratori, G Di Sacco, et al.
Henry Ford Hospital Medical Journal|January 1, 1989
Use of somatostatin analog SMS 201-995 in medullary thyroid carcinomaA Libroia, U Verga, G Di Sacco, et al.
Henry Ford Hospital Medical Journal|January 1, 1992
Evaluation of children with medullary thyroid carcinomaA Libroia, F Muratori, U Verga, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Loss of heterozygosity at the RET protooncogene locus in a case of multiple endocrine neoplasia type 2AL Quadro, O Fattoruso, M P Cosma, et al.
Journal of Endocrinological Investigation|May 19, 1998
Seventeen-year-long follow-up of a family affected by type 2A multiple endocrine neoplasia (MEN 2A)A Libroia, U Verga, G Vecchi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 1997
A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinomaR M Hofstra, O Fattoruso, L Quadro, et al.
Clinical Endocrinology|September 27, 2005
Ghrelin in human medullary thyroid carcinomasP S Morpurgo, V Cappiello, U Verga, et al.
Molecular and Cellular Endocrinology|June 2, 1998
Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomasC Scurini, L Quadro, O Fattoruso, et al.
Journal of Endocrinological Investigation|March 15, 2005
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomasM Filopanti, E Ballarè, A G Lania, et al.
Pageof 1